Stock Analysts’ Downgrades for September, 7th (ASUR, BBRG, CRZO, DDC, FRGI, KAR, OMAB, RACE, RSTGF, RTTR)

Stock Analysts’ downgrades for Thursday, September 7th:

Asure Software (NASDAQ:ASUR) was downgraded by analysts at Scotiabank from an outperform rating to a sector perform rating.

Bravo Brio Restaurant Group (NASDAQ:BBRG) was downgraded by analysts at Piper Jaffray Companies from a neutral rating to an underweight rating.

Carrizo Oil & Gas (NASDAQ:CRZO) was downgraded by analysts at Mizuho from a buy rating to a neutral rating. Mizuho currently has $47.00 price target on the stock.

Dominion Diamond Corporation (NYSE:DDC) (TSE:DDC) was downgraded by analysts at Scotiabank from an outperform rating to a sector perform rating.

Fiesta Restaurant Group (NASDAQ:FRGI) was downgraded by analysts at Piper Jaffray Companies from a neutral rating to an underweight rating.

KAR Auction Services (NYSE:KAR) was downgraded by analysts at Stephens from an overweight rating to an equal weight rating.

Grupo Aeroportuario del Centro Norte S.A.B. de C.V. (NASDAQ:OMAB) was downgraded by analysts at Scotiabank from a sector perform rating to an underperform rating.

Ferrari N.V. (NYSE:RACE) was downgraded by analysts at Morgan Stanley from an overweight rating to an underweight rating.

Restaurant Group (NASDAQ:RSTGF) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Restaurant Group plc operates branded restaurants and pubs. Its brand portfolio includes Frankie & Benny’s, Chiquito, Coast to Coast, Garfunkel’s, Brunning & Price, Joe’s Kitchen and TRG Concessions. The company operates primarily in United Kingdom. Restaurant Group plc is based in London, United Kingdom. “

Ritter Pharmaceuticals (NASDAQ:RTTR) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ritter Pharmaceuticals, Inc. is involved in developing therapeutic products to treat inflammatory, gastrointestinal and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. Ritter Pharmaceuticals, Inc. is headquartered in Los Angeles, California. “

Revance Therapeutics (NASDAQ:RVNC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. Revance’s science is based upon a proprietary TransMTS® peptide technology, which when combined with active drug molecules, may help address current unmet needs. Revance’s initial focus is on developing daxibotulinumtoxinA, the company’s highly purified botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company’s lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines and cervical dystonia and has the potential to be the first long-acting neurotoxin. The company holds worldwide rights for all indications of RT002 injectable and RT001 topical and the pharmaceutical uses of the TransMTS technology platform. “

Sealed Air Corporation (NYSE:SEE) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating.

Stora Enso OYJ (NASDAQ:SEOAY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Stora Enso is an integrated forest products company producing magazine papers, newsprint, fine papers and packaging boards, areas in which the Group is a global market leader. Stora Enso also conducts extensive sawmilling operations. To strengthen its market position and better serve customers in the United States, the company acquired the U.S.-based, Consolidated Papers, Inc. in 2000. “

Sumitomo Mitsui Financial Group (NYSE:SMFG) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “SUMITOMO MITSUI FINANCIAL GROUP, INC., is a financial holding company established through a share transfer from Sumitomo Mitsui Banking Corporation. As a holding company, SMFG has functions such as strategic planning, management, resource allocation, strategic planning of information systems, financial management, investor relations, risk management, human resource management for group executives, and business auditing of the group as a whole. Sumitomo Mitsui Card Company, Limited, SMBC Leasing Company, Limited, SMBC Friend Securities and The Japan Research Institute are wholly-owned subsidiaries of SMFG. “

SENIOR GBP0.10 (NASDAQ:SNIRF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Senior PLC provides engineering solutions. The Company designs, manufactures and markets technology components and systems for the equipment producers primarily in the aerospace, defence, land vehicle and energy markets. Its operating segment consists of Aerospace and Flexonics. Senior PLC is based in Rickmansworth, the United Kingdom. “

Tabula Rasa Healthcare (NASDAQ:TRHC) was downgraded by analysts at Wells Fargo & Company from an outperform rating to a market perform rating.

Trivago N.V. ADS (NASDAQ:TRVG) was downgraded by analysts at Bank of America Corporation from a buy rating to a neutral rating.

Varian Medical Systems (NYSE:VAR) was downgraded by analysts at BTIG Research from a buy rating to a neutral rating. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.